Novartis beats top-line and bottom-line estimates; reaffirms FY26 outlook
Earnings Seeking Alpha Jul 21, 2026
Novartis beats top-line and bottom-line estimates; reaffirms FY26 outlook
Novartis beats top-line and bottom-line estimates; reaffirms FY26 outlook
Earnings Seeking Alpha Jul 21, 2026